Intellia Therapeutics Stock Moves Higher After Capital Raise Of $600M Issued At $145/Share

by Vandana Singh, Benzinga Editor

June 30, 2021 7:11 AM | 1 min read |

Intellia Therapeutics Inc NTLA has priced a previously announced public offering at $145 per share, representing a discount of 4.4% from the last close price of $151.6 on Tuesday.
The company is offering around 4.1 million shares, and underwriters can purchase up to an additional 620,689 shares.
Gross proceeds will be approximately $600 million.
Goldman Sachs & Co. LLC, Jefferies, SVB Leerink, and Barclays are the joint book-running managers for the offering.
Truist Securities is acting as co-manager for the offering.
The offering will close by July 2.
Price Action: NTLA shares are up 1.71% at $154.20 during the premarket session on the last check Wednesday.

Posted In:

Biotech News Health Care Financing Offerings General Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.